Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali

PHASE4CompletedINTERVENTIONAL
Enrollment

1,139

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

December 31, 2008

Study Completion Date

April 30, 2015

Conditions
Lymphatic Filariasis
Interventions
DRUG

''albendazole'' and ''ivermectin''

annual single dose administration of albendazole 400mg and ivermectin 150ug/kg of weight (according to the height)

All Listed Sponsors
collaborator

Malaria Research and Training Center, Bamako, Mali

OTHER

collaborator

World Health Organization

OTHER

lead

Centre d'Appui à la lutte contre la Maladie

OTHER

NCT02784743 - Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali | Biotech Hunter | Biotech Hunter